SE7414960L - - Google Patents

Info

Publication number
SE7414960L
SE7414960L SE7414960A SE7414960A SE7414960L SE 7414960 L SE7414960 L SE 7414960L SE 7414960 A SE7414960 A SE 7414960A SE 7414960 A SE7414960 A SE 7414960A SE 7414960 L SE7414960 L SE 7414960L
Authority
SE
Sweden
Application number
SE7414960A
Other versions
SE408426B (sv
Inventor
U Kerb
R Wiechert
K Kieslich
K Petzoldt
H Wachtel
D Palenschat
R Horowski
G Paschelke
W Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7414960L publication Critical patent/SE7414960L/xx
Publication of SE408426B publication Critical patent/SE408426B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
SE7414960A 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner SE408426B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
SE7414960L true SE7414960L (de) 1975-06-02
SE408426B SE408426B (sv) 1979-06-11

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414960A SE408426B (sv) 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner

Country Status (14)

Country Link
US (1) US4045574A (de)
JP (1) JPS5084561A (de)
AT (1) AT347611B (de)
CA (1) CA1030522A (de)
CH (1) CH618183A5 (de)
DD (1) DD115659A5 (de)
DK (1) DK134348C (de)
ES (1) ES432106A1 (de)
FR (1) FR2253512B1 (de)
GB (1) GB1494097A (de)
IE (1) IE40423B1 (de)
IL (1) IL46153A (de)
NL (1) NL7415577A (de)
SE (1) SE408426B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
EP1534732B1 (de) * 2002-08-16 2006-09-13 Pharmacia & Upjohn Company LLC 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
AU2014256229B2 (en) 2013-04-17 2018-10-04 Sage Therapeutics, Inc. 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
PL3021852T3 (pl) 2013-07-19 2021-07-05 Sage Therapeutics, Inc. Neuroaktywne steroidy, kompozycje i ich zastosowania
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス， インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
WO2016061527A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
PL3250210T3 (pl) 2015-01-26 2021-07-26 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
JP7049313B2 (ja) 2016-07-11 2022-04-06 セージ セラピューティクス， インコーポレイテッド Ｃ１７、ｃ２０、およびｃ２１置換神経刺激性ステロイドおよびそれらの使用方法
ES2992037T3 (es) 2016-07-11 2024-12-05 Sage Therapeutics Inc Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización
AR114044A1 (es) * 2017-12-22 2020-07-15 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos en el sistema nervioso central
TWI874337B (zh) 2018-12-05 2025-03-01 美商賽吉醫療公司 神經活性類固醇及其使用方法
EP3909967A4 (de) 2019-01-08 2022-11-09 Chengdu Kanghong Pharmaceutical Co., Ltd. Steroidverbindung und verwendung davon und herstellungsverfahren dafür
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)
CA3143545A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders
KR20220038681A (ko) * 2019-06-27 2022-03-29 세이지 테라퓨틱스, 인크. Cns 장애를 치료하기 위한 조성물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK134348B (da) 1976-10-25
US4045574A (en) 1977-08-30
CH618183A5 (de) 1980-07-15
IE40423B1 (en) 1979-05-23
AT347611B (de) 1979-01-10
DK604174A (de) 1975-07-28
SE408426B (sv) 1979-06-11
IL46153A (en) 1979-01-31
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
IL46153A0 (en) 1975-02-10
CA1030522A (en) 1978-05-02
NL7415577A (nl) 1975-06-03
FR2253512A1 (de) 1975-07-04
DD115659A5 (de) 1975-10-12
FR2253512B1 (de) 1978-02-03
GB1494097A (en) 1977-12-07
JPS5084561A (de) 1975-07-08
ATA950774A (de) 1978-05-15
DK134348C (da) 1977-03-21
AU7586774A (en) 1976-06-03

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AR201235Q (de)
AR201231Q (de)
AU495860B2 (de)
FR2253512B1 (de)
AR201229Q (de)
AR195948A1 (de)
AR200256A1 (de)
AR200885A1 (de)
AR193950A1 (de)
AR195311A1 (de)
AR196382A1 (de)
AR210729A1 (de)
AR197627A1 (de)
AR196123Q (de)
AR196212Q (de)
AU1891376A (de)
CH566530A5 (de)
BG20687A1 (de)
CH567692A5 (de)
CH567203A5 (de)
CH568463A5 (de)
CH565634A5 (de)
AU479422A (de)
CH563536A5 (de)